Epidemiological evidence suggests that low levels of vitamin D may predispose people to develop depression and cognitive impairment. While rodent studies have demonstrated that prenatal vitamin D deficiency is associated with altered brain development, there is a lack of research examining adult vitamin D (AVD) deficiency.
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Introduction
The role of vitamin D in adult brain function has attracted considerable attention in recent years [1] . Apart from the well-established role in calcium homeostasis, key features of the vitamin D system have been identified in the central nervous system. For example, the vitamin D receptor and the key enzyme required for its activation, 25-OH D 3 1α hydroxylase, has been identified in both neuronal and glial cells in the human brain [2] . Vitamin D has been linked to key neurotrophic agents, such as nerve growth factor and glial cell-derived neurotrophic factor [3, 4] , and animal experiments have suggested that the active form of the vitamin has 'neuroprotective' features. For example, pre-treatment with vitamin D attenuates the effects of various stressors, including 6-hydroxydopamine-induced neurotoxicity [5, 6] . Moreover, vitamin D deficiency in adult rats has been shown to exacerbate stroke injuries and lead to more severe post-stroke behavioural impairments and this was accompanied by lower levels of the neuroprotective hormone, insulin-like growth factor 1 [7] .
Clues from epidemiology suggest that developmental vitamin D (DVD) deficiency may be associated with an increased risk of schizophrenia [8] and there has been considerable focus on animal models that examine the impact of DVD deficiency on brain related outcomes [9] [10] [11] . For example, rats exposed to DVD deficiency have decreased expression of nerve growth factor [4] . They also have ventricular enlargement as neonates [9] a finding that persists through to adulthood [4] . DVD 4 neonates have alterations in catechol-O-methyl transferase expression and dopamine metabolism [12] and early alterations in dopamine ontogeny [13] . Links between dopamine and vitamin D have also been identified in adult animals. Vitamin D has been shown to promote the synthesis of tyrosine hydroxylase, the rate-limiting enzyme of dopamine synthesis and also to increase basal levels of dopamine within the central nervous system after localised injection of vitamin D 3 [6, 14] .
The research community has become more aware of the role of vitamin D in adult brain function and epidemiological studies have examined links with various neuropsychiatric disorders. For example, cross-sectional studies have reported significant associations between low concentrations of 25-OH D 3 in adults and various indicators of cognitive function, including memory and orientation [15] [16] [17] , executive function [18, 19] , and diagnosis of dementia and Alzheimer's disease [20] .
A recent prospective study [21] found that baseline vitamin D deficiency was associated with greater impairment of cognitive tasks in subsequent years. However, other studies have not found an association between vitamin D status and brain outcomes [22] [23] [24] .
Studies on European populations have shown that second generation dark-skinned migrants (with a reduced ability to generate vitamin D from sunlight) have an increased risk of being diagnosed with schizophrenia compared to other immigrants and an even greater risk compared to the native born [25] . Vitamin D deficiency has been linked to a number of other neurological disorders including autism [26] , seasonal affective disorder [27, 28] , and multiple sclerosis [29] . Cross-sectional studies have reported an association between vitamin D status and depressive symptoms [30] . A prospective study reported that women with low levels of vitamin D at baseline reported higher levels of depressive symptoms 3 and 6 years later [31] . 5 To date, there has only been one study to investigate the impact of AVD deficiency on brain function and behaviour in rodents [32] . However, in that study the SpragueDawley rats were fed a vitamin D deficient diet from weaning and they had reduced body weight compared to controls, which suggests that musculoskeletal problems may have confounded interpretation of behavioural outcomes in the study. AVD deficiency has previously been associated with altered catecholamine metabolism in the cortex of Sprague-Dawley rats, with alterations in the levels of noradrenaline and dihydroxyphenylacetic acid, a breakdown product of dopamine [33] . However, there was no behavioural data reported. Thus, to our knowledge there are no published data on the impact of AVD deficiency on mouse behaviour or brain function and thus it is difficult to predict how this may impact on different behavioural domains or brain neurochemistry in mice.
The aim of this study was to establish a model of AVD deficiency in two strains of mice and to examine a broad range of behavioural tests and selected neurochemical outcomes within the brain. BALB/c and C57BL/6J strains were chosen for this study because they are inbred strains that are commonly used in biomedical research, and show markedly different behavioural phenotypes [34] . The overarching aim of this work was to establish a model of adult vitamin D deficiency, rather than model a single neuropsychiatric disorder. Indeed, a recent review highlighted the fact that vitamin D deficiency is associated with a range of neuropsychiatric outcomes [11] .
As such we used a multi-tiered behavioural test battery to broadly assess the behavioural domains of locomotion, exploration, anxiety, social behaviour, learned helplessness, sensorimotor gating, associative learning, and nociception, as well as responses to the psychomimetic agents D-amphetamine and MK-801. These behavioural tasks are relevant to a number of neuropsychiatric disorders including 6 pyschosis, schizophrenia, anxiety and depression. Neurochemical profiles were analysed in drug-naïve mice in order to explore the effect of AVD deficiency on levels of catecholamines and amino acids, as well as selected enzymes involved with key neurotransmitters.
Materials and Methods
Animals and housing
A total of 148 male mice were used in this study (79 x C57BL/6J and 69 x BALB/c). Deficient AIN93G Rodent diet, Specialty Feeds, WA, Australia) for a minimum of 10 weeks prior to the start of behavioural testing; and for the entire duration of the experimental procedures. The mice were maintained on a 12-hour light-dark cycle (lights on at 07:00 h) with ad libitum access to food and water. They were housed under incandescent lighting free from UVB radiation. All experimental work was performed with approval from the Griffith University Animal Ethics Committee, under the guidelines of the National Health and Medical Research Council of Australia.
Procedure
Behavioural phenotyping began when the on postnatal day 140 (P140). Mice were exposed to a variety of tests assessing various behavioural domains. The tests were 7 performed on separate days and in the following order (approximate age of mice at each test); open field (P140), elevated plus maze (P168), holeboard (P169), light/dark test (P170), forced swim test (P171), prepulse inhibition of the acoustic startle response (P175), active avoidance (P182), social interaction (P189), hot plate test (P196). Sixteen C57BL/6J mice (n = 8/diet) and sixteen BALB/c mice (n = 8/diet) were subjected to the behavioural test battery, with additional mice from each strain tested in the novel open field (n = 28/diet/strain), ASR, and PPI of ASR (n = 20/diet/strain). Behaviours were recorded by two methods, either by video recording software (Miglia TV, Hertfordshire, UK) or a USB webcam and recording software (Media Player) and analysed by computer tracking software (Ethovision, Noldus, Wageningen, The Netherlands). All apparatus was cleaned before and after each mouse with 80% ethanol.
Open Field
The open field test was used to measure baseline locomotion [35] . The open field apparatus was an opaque box (28 cm high x 30 cm x 30 cm), in which the mice were placed in the centre of the arena. The test lasted for 30 min, during which time both total distance travelled and distance travelled over time were analysed to assess locomotion. Locomotion was assessed in a novel environment, and also in a familiar environment, with a subset of mice (n=9-10 per group) re-exposed to the same open field arena 7 weeks later.
Elevated plus maze
The elevated plus maze was used to measure anxiety-related behaviour [36] . The elevated plus maze was made of opaque grey acrylic, and was attached to a stand, 
Holeboard Test
The holeboard test was used to measure exploration based on the frequency of head-dipping into small holes situated in the floor of an open field [37] . A white acrylic base containing four evenly spaced holes (2.5 cm diameter), was added to the bottom of a black box (30 cm high x 30 cm x 30 cm) to create the holeboard. The mice were initially placed along the edge of the wall and the number of head-dips in a 10 min period was analysed, along with the total distance travelled.
Light/dark test
The light/dark test was used in the behavioural test battery to aid in the analysis of anxiety levels of the mice [38] 
Forced swim test
The forced swim test was used to measure learned helplessness [39] . The apparatus used in the forced swim test was a clear round container (20 cm high x 13 cm diameter) with a column of water (16 cm deep) maintained at 25 °C, from which the mouse could not escape. The percentage of time the mouse spent immobile in each one min time bin, over a 10 min period was the parameter analysed.
Prepulse inhibition of the acoustic startle response
PPI of the ASR was used to measure sensorimotor gating [40] 10 The active avoidance test was used to measure associative learning, using a conditioned avoidance response [41] . The active avoidance chambers (Gemini, CA, USA) consisted of two compartments (18 cm high x 26 cm x 21 cm) separated by a guillotine door (10 cm high x 7 cm) above a barrier. Testing began with a 300 s acclimatisation period followed by 80 trials. Each trial was comprised of a 4 s Active avoidance for each mouse was analysed over 3 consecutive days. The first two days followed the above method for acquisition and retention; with the third day, a test of extinction, in which the unconditioned stimulus was removed. Each trial still began with the 4 s conditioned stimulus, but was followed by 16 s with no stimulus, in order to test the mouse's ability to learn a new response to the original conditioned stimulus.
Active avoidance
Social interaction test
The social interaction test was used to measure the behavioural responses of two unfamiliar, diet and weight matched mice to each other [42] . The test was conducted in an open field arena and behaviours were analysed over a 10 min period. A variety of behaviours were assessed including sniffing, self-grooming, allo-grooming, following and rearing.
Hot plate test
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The hot plate test was used to measure a response to noxious stimuli [43] . The hot plate (Harvard Apparatus, Ltd., Kent, England) was maintained at 53 °C, with the mice contained on the hot plate within a clear Perspex cylinder (27 cm high x 20 cm diameter). The test consisted of three trials, of a maximum length of 30 s. The parameter measured was the latency to lick hind paw or to jump with both feet, in an attempt to escape. The mouse was removed immediately after this was achieved. If this was not achieved by the end of the 30 s, the mouse was removed and the trial ended. The inter-trial period was 60 s.
Brain Neurochemistry
Tissue Collection
Body weight was monitored on a fortnightly basis throughout the study for all mice.
At the time on euthanasia, body measurements were taken from both strains of mice, for body length (from tip to snout to base of tail) and tail (from base to tip).
Brains were collected from drug-naïve mice subjected to the behavioural test battery.
Mice were euthanized by carbon dioxide followed by decapitation. The whole brain was removed and weighed. Using free-hand dissection, each brain was sectioned into left and right cerebrum and hindbrain, with olfactory bulbs removed. Tissue was frozen on dry ice and stored at -80 C until further processing.
High performance liquid chromatography and analysis
Catecholamines and amino acids from brain tissue were measured by high performance liquid chromatography with electrochemical and fluorescent detection using a standard protocol. Data was stored and processed with ChemStation software (B1.03.02, Agilent Technologies, Inc., CA, USA). Data was quantified by calculating peak-area ratios of each compound compared to deoxyepinephrine (catecholamine internal standard) or homoserine (amino acid internal standard) and corrected for dilution. Identity of each compound was determined by retention time and the final amount was expressed as nanogram per gram (ng/g) wet tissue.
Protein analysis
Brain tissue was analysed for protein content using western analysis. 
Behavioural Pharmacology
The open field arena was used to assess behaviour in response to two 
Psychomimetic Drugs
D-amphetamine (Sigma, MO, USA) was diluted to a concentration of 1.25 mg/ml in 0.9 % saline solution and aliquots were stored at -20 °C. Mice were given an injection dose of 5 mg/kg. MK-801 (Sigma, MO, USA) was diluted to a concentration of 0.125 mg/ml in 0.9 % saline solution and aliquots were stored at -20 °C. Mice were given an injection dose of 0.5 mg/kg. The drug dosage used was based on previous studies showing a high locomotor response with little stereotypic or ataxic behaviours [44, 45] .
Blood chemistry
At the completion of experimental procedures, a terminal blood sample was taken from each mouse via cardiac puncture. The levels of 25-OH D 3 was measured in serum samples using liquid chromatography-tandem mass spectrometry (Sciex Instruments, ON, Canada) on a 4000 QTrap API AB mass spectrometer [46] . BALB/c control: 32.0 ± 1.7 nM, AVD-deficient: 2.9 ± 0.2 nM, and C57BL/6J control: 65.3± 2.3 nM, AVD-deficient: 2.9 ± 0.1 nM.
Calcium levels (n=17-19) were measured in serum samples using the QuantiChrom Assay Kit using quantitative colormetric determination (BioAssay Systems, CA, USA) and were not significantly different between groups. BALB/c control: 2.33 ± 0.15 mM, AVD-deficient: 2.20 ± 0.09 mM, C57BL/6J control: 2.28 ± 0.09 mM, AVD-deficient: 2.13 ± 0.10 mM).
Statistical analysis
Results were analysed for statistical significance using SPSS (version 17.0) software. All data were analysed for the main effects of Diet (control or AVDdeficient) and Strain (C57BL/6J or BALB/c) using analysis of variance (ANOVA) or, where appropriate, repeated measures ANOVA. Mann-whitney U test was used to analyse non-parametric data. Significant differences (p<0.05) were followed up with post-hoc t-tests.
Results
Open Field
The locomotor response was measured both in a novel environment and in a familiar environment. Overall, AVD-deficient mice from both strains exhibited increased locomotion compared to the controls in a novel environment (F 1,108 = 11.18, p = 0.001) (Fig.1a and b ). There was a significant effect of Diet in both BALB/c ( (Fig.1c and d) .
<<Insert Fig. 1 about here>> 
Elevated plus maze
On the elevated plus maze, all mice entered the closed arms and all but two control Compared to controls, the BALB/c AVD-deficient mice spent a significantly longer time on the open arms ( Fig. 2a and b) . There was no significant effect of Diet for the C57BL/6J mice (F 1,14 = 0.43, p = 0.839). There was a significant main effect of Strain (F 1,28 = 10.07, p = 0.004) on the distance travelled while on the elevated plus maze with C57BL/6J mice travelling further than the BALB/c mice, however, there was no significant effect of Diet on total distance travelled.
<<Insert Fig. 2 about here>> 
Holeboard test
In the holeboard test, all mice poked their noses into the holes. There was a significant main effect of Strain on the frequency of head-dipping ( 
Light/dark test
All mice entered the light chamber at least once during the test. There was no significant effect of Diet or Strain on the time to emerge, however, there was a significant effect of Strain on the frequency to enter the light chamber (F 1,28 = 22.89, p <0.001). There was no effect of Diet on any measure on the light/dark test.
Forced swim test
All mice became increasingly immobile over the course of the forced swim test. There was no significant difference in the time spent immobile between diet groups from either strain. However, there was a significant effect of Strain (F 1,28 = 417.48, p <0.001) with the BALB/c mice spending a greater amount of time immobile than the C57BL/6J mice.
Prepulse inhibition of the acoustic startle response
All mice responded to increasing pulse amplitude with increased startle response. 
Active avoidance
Mice of each strain responded quite differently to the test of avoidance learning and some of the BALB/c mice had difficulty learning the avoidance paradigm all together.
There was a significant Diet x Strain interaction for acquisition of learning (Day 1) (F 1,28 = 4.63, p = 0.040). There was no significant effect of Diet on the latency to escape in C57BL/6J mice but there was a significant effect of Diet on the latency to escape for BALB/c mice during acquisition (F 1,14 = 6.44, p = 0.024) (Fig. 3a and b) . There was no significant effect of Diet for the C57BL/6J mice on any of the response scores (avoid, escape or no response) on Day 1 or over the 3-day test. There was a significant effect of Diet (F 1,14 = 6.62, p = 0.022) for the BALB/c mice on the no response score on Day 1 of the test; the AVD-deficient mice made fewer no response scores than the controls. The effect of Diet on the no response score over the 3-day test did not reach significance (F 1,30 = 4.05, p = 0.053).
Social interaction test
In the social interaction test there was no significant effect of Diet on either strain for any measure analysed. There were significant effects of Strain for following (F 1,25 = 29.82, p <0.001) and rearing (F 1,25 = 60.63, p <0.001) with BALB/c mice having reduced following and rearing compared to the C57BL/6J mice.
Hot plate test
On the first trial of the hot plate test, there was a significant main effect of Strain (Fig. 3c and d) . Glutamine and glutamate levels were significantly lower in the AVD-deficient mice, whereas levels of glycine, lysine, and GABA were significantly higher in the AVDdeficient mice (Table 1 ).
There was a significant effect of Diet on the levels of 5-hydroxyindoleacetic acid Table 2. <<Insert Table 1 showing greater amphetamine-induced locomotion than the BALB/c mice ( Fig. 5a and b). There was no significant main effect of Diet (F 1,28 = 0.99, p = 0.329) or Strain (F 1,28 = 2.65, p = 0.115) on the locomotor response to MK-801 ( Fig. 5c and d) . were hyper-explorative on the hole-board test [40] . Adult DVD deficient rats are more active than controls in novel environments [47, 48] , show an increased psychomimetic-induced hyperlocomotion and an enhanced startle response after MK-801 injection [49, 50] . This suggests that the absence of vitamin D may lead to alterations in similar neural circuits in both the developing and adult brain.
With respect to schizophrenia, the AVD mice did not replicate behavioural features typically seen in other animal models of schizophrenia. For example, two prominent features include deficits in PPI [51] and enhanced locomotor response to amphetamine [49] . These features are both based on alterations in dopamine metabolism, with the dopaminergic system being strongly implicated in the development of schizophrenia [52] . Moreover, although DVD-deficient rats show enhanced MK-801 induced locomotion [48, 50] this was not seen in DVD-deficient 22 129/SvJ or C57BL/6J mice [45] or in AVD-deficient BALB/c or C57BL/6J mice in the current study.
However, the AVD-deficient BALB/c mice had alterations in glutamate and glutamine levels in brain tissue, which may indicate a disruption in glutamatergic neurotransmission. There is mounting evidence to suggest that NMDA receptor dysfunction may contribute to schizophrenia symptoms, particularly those that are not relieved by antipsychotics. This dysfunction may be related more to the negative and cognitive symptoms of schizophrenia [53] . It has also been suggested that non-NMDA receptor dysregulation may be involved in schizophrenia [54] . While the alterations in glutamate metabolism seen in the AVD-deficient BALB/C mice did not translate into known behavioural features of schizophrenia, this does not rule out the relevance these mice might have in schizophrenia research and for other neurological disorders, such as anxiety.
The underlying neurobiological mechanisms of the behaviour of AVD deficient mice remain to be clarified. Despite a consistent decrease in GAD65/67 levels in both strains of mice used in this study, there was little overlap between strains for changes seen in brain neurochemistry. The small but significant reduction in GAD65/67 levels may be highly relevant to psychiatric conditions in which altered GABAergic neurotransmission has been implicated, including schizophrenia [55] , autism [56] , anxiety [57] , depression [58] , bipolar disorder [57, 59] and obsessive compulsive disorder [57, 60] . For example, reductions in GAD67 in parietal cortex and GAD65 in cerebellum were shown in post mortem brain tissue from autistic patients when compared to controls [61] . Another study reported global reductions in levels of GAD65/67 in the cerebella of subjects with schizophrenia, bipolar disorder and major depression [59] . Despite reports of small global reductions in GAD 65/67 these changes were shown to be accounted for by alterations in distinct subpopulations of neurons, including the larger-sized GABAergic dentate cells within the cerebellum [62] . In the current study subtle variations in specific brain regions or cell populations could not be detected as all analyses were performed on whole brain homogenates. Future studies would need to investigate localised changes in defined cell populations.
The two strains used in this study differed on a range of physiological parameters, behavioural responses, and drug-induced behaviours, as well as in levels of several neurochemicals. The non-emotional, high locomotor C57Bl/6 strain showed very little effect of AVD deficiency except spontaneous hyperlocomotion, while the highly emotional, neophobic BALB/c strain showed significant effects of AVD deficiency, particularly involving limbic system functions. One of the major differences found between BALB/c and C57Bl/6 mice is the strong defensive behaviour the BALB/c mice show in response to unfamiliar places (neophobia). This is proposed as 'trait' anxiety, a stable characteristic of behaviour. Administration of benzodiazepines is able to abolish neophobia in BALB/c mice, whereas several other anxiolytic compounds cannot. Benzodiazepines are also devoid of anxiolytic effects in C57Bl/6 mice [63] . The BALB/c strain shows a significant reduction in benzodiazepine receptor density compared to the C57Bl/6 strain [64] . This may at least in part explain the genetically determined predisposition to anxiety seen in the BALB/c mice. The biological consequences of relatively small changes in neurotransmitter levels remains to be established. However, we found significant strain differences in the effect of AVD deficiency on catecholamine, indolamine and amino acid levels, with a predominantly catecholamine/indolamine phenotype in C57BL/6 mice and a predominantly amino acid phenotype in BALB/c mice. There is significant variation between C57BL/6 and BALB/c mice on metabolic protein levels in brain tissue. For example, differences were shown for nucleic acid, amino acid and carbohydrate metabolism in proteomic analysis of hippocampal tissue from these strains of mice [67] . Strain dependent regulation of amino acid metabolism could explain why AVDdeficiency had a greater impact on GABAergic and glutamatergic neurotransmitter systems in BALB/c mice. With respect to indolamine levels (5-HT and 5-HIAA) C57BL/6 mice have approximately 50% higher rates of 5-HT synthesis than BALB/c mice because of a single nucleotide polymorphism in the mTph2 gene (C1473G) [68] , which may lead to a greater vulnerability in AVD-deficient C57BL/6 mice when compared with BALB/c mice.
The AVD-deficient BALB/c mice had a small increase in the levels of GABA and glycine, and decreased levels of glutamate and glutamine in brain tissue. GABA is the major inhibitory neurotransmitter in the brain and it is synthesised from glutamate by two isoforms of GAD; GAD65 and GAD67. Reduced levels of GAD65/67 are typically associated with a reduction in GABA synthesis. However, we observed an increase in GABA levels in AVD-deficient BALB/c mice and, despite a similar reduction in GAD65/67 levels in C57BL/6 mice, there were no significant changes to either glutamate or GABA levels in this strain. The mechanism/s by which vitamin D deficiency could lead to increases in GABA are unknown. However, recent studies in developing zebrafish indicate that the active metabolite of vitamin D affects a wide range of genes, including those involved with amino acid metabolism [69] , although similar studies have not been carried out in rodents. It was shown that GAD65 KO mice maintain normal levels of GABA content in brain [70] and the overall reduction in GAD enzymes may signify a reduced conversion of glutamate to GABA, but differences in biochemical alterations following a reduction in GAD65/67 may vary between BALB/c and C57BL/6 mice.
Positive modulators of GABAergic neurotransmission that function to increase GABA brain levels produce anxiolytic effects in rodent models of anxiety [71] .
Chlordiazepoxide is an anxiolytic, GABA-enhancing agent, which, when given to BALB/c mice, produces several of the behavioural outcomes seen in this study. We did not compare directly the effects of critical periods of vitamin D deficiency (i.e. gestational versus adult) in the current study. Data from developmental studies 27 indicates that a number of different mechanisms may exist by which vitamin D impacts both during brain development and on adult, from altered proliferation, apoptosis or mitosis [11] . There are no data on developmental vitamin D deficiency in BALB/c mice. We have published data to show that DVD C57BL/6 mice also show hyperlocomotion (Harms et al., 2008 ) and this would suggest that there may be a similar impact on the developing and adult brain. Comparisons between developmental and adult vitamin D deficiency in BALB/c mice would need to be carried out to address this question directly. In addition, the current findings were from male mice and these may not be generalizable to female mice and so these studies would also need to be performed.
The results from the current study show that adult vitamin D deficiency has effects on behaviour and brain function in two inbred mouse strains. We found alterations consistent across both strains (hyperlocomotion and reduced GAD65/67) with many being altered only in the BALB/c strain, which was more susceptible to AVD than C57Bl/6. This suggests that our findings are not generaliseable to all mouse strains, although this is likely to be the case for many manipulations, for example environmental enrichment has strain specific effects on behaviour [75] . The current findings suggest that both excitatory and inhibitory neurotransmitter systems are affected by vitamin D deficiency in adult mice, which may be further exacerbated by the background strain or by detrimental environmental exposures or genomic instability. With vitamin D deficiency becoming increasingly recognised throughout the world [76, 77] , it is important to determine to what extent vitamin D deficiency contributes to adverse brain outcomes in light of the fact that supplementation is readily available. In particular, the findings seen in the AVD-deficient BALB/c mice 
